CD47-SIRPα checkpoint disruption in metastases requires tumor-targeting antibody for molecular and engineered macrophage therapies
收藏数据链接：
官方服务：
资源简介：
Data for the Cancers (2022) publication: CD47-SIRPα checkpoint disruption in metastases requires tumor-targeting antibody for molecular and engineered macrophage therapies
提供机构：
figshare创建时间：
2022-04-08
